On 17 October 2025, the FTSE 100 fell sharply. Markets were hit by growing fears around U.S. regional banks. Two such banks disclosed large loan losses and fraud risks. This news shocked investors globally.
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
Silver prices took a sharp hit on January 16, 2026, sending a strong signal across India’s commodity market. On the Multi Commodity Exchange (MCX), silver futures dropped by more than ₹4,000 per kilogram in a single session. The fall surprised many traders who were still tracking silver’s recent highs. Continue Reading on Meyka This article…
At the heart of the APEC Summit 2025 in Busan, South Korea, the landmark meeting between U.S. President Donald Trump and Chinese President Xi Jinping has launched a pivotal phase in global trade policy. This “South Korea Summit” signals renewed efforts between the world’s two largest economies to ease tariffs, stabilise supply chains, and address…
In a strong start to the trading week, the Sensex climbed about 250 points today as Indian stock markets continued to show resilient momentum. The Nifty 50 index remained above the 25,900 mark for the third consecutive trading session, signaling sustained investor confidence in equities. Smallcap stocks outperformed the headline indices, adding further breadth to…
In a remarkable development for India’s clean energy sector, Suzlon Energy has secured a massive 838 MW order from Tata Power Renewable Energy Limited (TPREL). This collaboration marks one of the largest renewable energy deals in recent years, reaffirming India’s commitment to achieving ambitious sustainability goals. Continue Reading on Meyka This article is available in…
The U.S. stock market began 2026 on a strong note. Major indexes like the Dow, S&P 500, and Nasdaq pushed higher in the first trading days of the year. Investors were hopeful that good earnings and lower interest rates would support more gains. Continue Reading on Meyka This article is available in full on our…
Emma Walmsley, the Chief Executive of GlaxoSmithKline (GSK), is stepping down after eight years of leading one of the world’s largest pharmaceutical companies. Her departure marks the end of a transformative era for the British drugmaker, which faced both breakthroughs and challenges under her leadership. Continue Reading on Meyka This article is available in full…